ABOUT THE PRODUCT
Ribometrix is developing small molecule therapeutics targeting eIF4E, a key regulator of mRNA translation, with potential applications in KRAS mutant non-small cell lung cancer.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from Ribometrix Inc.
RNA-Targeting Small Molecule Platform
Biotechnology
N/A
Ribometrix Inc.
United States (US)